Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.
Saved in:
| Title: | Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Shore, Neal1 (AUTHOR) nshore@auclinics.com, Nguyen2 (AUTHOR), Kang, Barinder2 (AUTHOR), Sawhney, Amrita2 (AUTHOR), Byrne, Clare3 (AUTHOR), Tang, Jackson3 (AUTHOR), Gorritz, Magdaliz4 (AUTHOR), Chen, Chi-Chang4 (AUTHOR), Patel, Jeetvan2 (AUTHOR) |
| Source: | International Journal of Clinical Oncology. Aug2026, Vol. 31 Issue 8, p1451-1471. 21p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
